Lines of Fate
The American Historical Review · 01.12.2024 · 129 (4) · 1451-1473
DOI: 10.1093/ahr/rhae470 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Historical Review, online erschienen am 05.12.2024. Verfasst von Ian M Miller und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
This article explores the concept of resilience within the framework of fengshui forests in subtropical southern China over the last millennium. Consisting of small patches of old-growth or old secondary-growth forest associated with graves, temples, and the paths of wind and water into and out of villages, fengshui forests were historically seen as nodes that supplied vital qi(energy, force or substance) to the community, an understanding that persists to the present day. Using a combination of textual, ethnographic, and scientific evidence, we examine how these forests, deeply embedded in the cultural and ecological fabric of the region, have fostered community resilience and sustainability over centuries. We show that fengshui’s vitalist and syncretic conception of the relationship among living people, ancestors, the land, and the trees allowed it to bridge Indigenous and imperial moral ecologies. By foregrounding both the emic and etic implication of fengshui, this article contributes to our understanding of Indigenous moral ecologies, the histories of social-ecological resilience, and the role of sacred forests in sustaining biodiversity and community well-being, past and present.
Zitieren
APA
Miller, I. M., & Coggins, C. (2024). Lines of Fate. The American Historical Review, 129(4), 1451-1473. https://doi.org/10.1093/ahr/rhae470
Vancouver
Miller IM, Coggins C. Lines of Fate. The American Historical Review. 2024;129(4):1451-1473. doi:10.1093/ahr/rhae470
BibTeX
@article{Miller2024,
author = {Miller, Ian M and Coggins, Chris},
title = {Lines of Fate},
journal = {The American Historical Review},
year = {2024},
volume = {129},
number = {4},
pages = {1451--1473},
doi = {10.1093/ahr/rhae470}
}
EUVIMED